Biotechnology medicine

Pharmaceutical Manufacturers Association, In Development Biotechnology Medicines, PMA, Washington, D.C., 1991. 

Terms such as biologic , biopharmaceutical and products of pharmaceutical biotechnology or biotechnology medicines have now become an accepted part of the pharmaceutical literature. However, these terms are sometimes used interchangeably and can mean different things to different people. 

Kalger GmbH, Neuberg, Germany Microzym-L Lactate Enzyme electrode Food, biotechnology, medicine... 

As used herein, biotechnology medicines or products of pharmaceutical biotechnology are afforded a much broader definition. Unlike the term biopharmaceutical , the term... 

Table 1.3. A summary of the definition of the terms biologic , biopharmaceuticaf and biotechnology medicine as used throughout this book. Reprinted from European Journal of Pharmaceutical Sciences, vol 15, Walsh, Biopharmaceuticals and Biotechnology, p 135-138, 2002, with permission from Elsevier Science...

Biotechnology medicine/ product of pharmaceutical biotechnology Biologic... 

Pharmaceutical product Biopharmaceutical Biotechnology medicine Biologic ... 

Walsh, G. (2002). Biopharmaceuticals and biotechnology medicines an issue of nomenclature. Eur. J. Pharmaceut. Sci. 

Excellent site, providing information on a wide range of pharmaceutical issues, including reports such as the annual Biotechnology Medicines in Development series. 

PhRMA (2004), 324 Biotechnology medicines in testing promise to bolster the arsenal against disease. Available at http //www.phrma.org/files/Biotech%20Survey.pdf (accessed February 2006). 

A method is presented for producing concentrate of dehydrated Jerusalem artichoke tubers. The novel product is characterized by a high content of micro- and macroelements (e.g., silicon, potassium, phosphorus, and magnesium). It provides a biologically active additive for foodstuffs, a base or component of food products, and can also be a source material for the production of inulin for use in the biotechnological, medicine, cosmetics, and pharmaceutical industries. 

New biotechnology medicines in development report (2002), available http //pharma. org, accessed May 25,2006. 

Definitions like those quoted above for patentable inventions in the EPC, which are mainly based on exclusions, always appear somewhat unsatisfactory. A list of examples for principally patentable subject matters in the field of biological or biotechnological medicines may provide a more positive orientation (see Table 8). It should be noted that until recently numerous countries still excluded many of these inventions. 

Copmann, T.L. (1991). Science is not the barrier to innovation in biotechnology medicine. In PMA Survey Report Biotechnology Medicines in Development (Washington, DC Pharmaceutical Manufacturers Association), p. 16. 

PMA Survey Report (1991). Biotechnology Medicines in Development (Washington, DC Pharmaceutical Manufacturers Association). 

Polybetaines are specialty polymers. Accordingly, they are typically discussed for high added value apphcations, or in cases where no satisfactory alternative materials exist. The apphcation fields of polybetaines comprise, for instance, the oil industry, hydrometallurgy, biotechnology, medicine, and catalysis. 

Small molecules can be easily pinocytosed by living cells, but nanopartides larger than 100 nm are not easily transferred to their interiors. It sometimes takes a few hours for such nanoparticles to enter inside the cells. Therefore manipulation of cells and inj ection of probe molecules and nanopartides are extremely important and their development is strongly needed to fulfill the promise of potential applications of spectroscopy and imaging in life sdence, biotechnology, medicine, and so on. 

Tauzin B. 418 Biotechnology Medicines in Testing Promise to Bolster the Arsenal Against Diseases. Medicines in Development, Biotechnology, 2006. 

He contrasted this definition with the term biotechnological medicine which could include semisynthetic compounds originally obtained from nature (paclitaxel being a good example) or antibiotics isolated from fermentation broths. 

---